Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Sanofi
  6. News
  7. Press Releases
    SAN   FR0000120578

SANOFI

(SAN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société SANOFI
07/27SANOFI : provides update on avalglucosidase alfa EU submission for patients with..
PU
07/22SANOFI : continues streamlining of established products with sale of dental care..
PU
07/20SANOFI : - US FDA approves fexinidazole as the first all-oral treatment for slee..
AQ
07/19SANOFI : US FDA approves fexinidazole as the first all-oral treatment for sleepi..
PU
07/16SANOFI : announces Paris 2024 Premium partnership for the Olympic and Paralympic..
PU
07/15SANOFI : Conversion of Kiadis to a private limited liability company postponed u..
PU
07/13SANOFI : streamlines Consumer Healthcare portfolio in Latin America with divesti..
PU
07/13SANOFI : announces Paris 2024 Premium partnership for the Olympic and Paralympic..
AQ
07/12SANOFI : - MenQuadfi demonstrates superior immune response against serogroup C m..
AQ
07/10SANOFI : MenQuadfi® demonstrates superior immune response against serogroup C me..
PU
07/07SWEDISH ORPHAN BIOVITRUM : Sobi to present data at the ISTH 2021 within rare hae..
AQ
07/02SANOFI : highlights scientific innovations in the field of rare blood disorders ..
PU
06/30SANOFI : Approximately €400million investment annually to accelerate end-to-end ..
PU
06/29SANOFI : launches dedicated vaccines mRNA Center of Excellence
AQ
06/28SANOFI : - Availability of the Q2 2021 Memorandum for modelling purposes
AQ
06/28SANOFI : - Libtayo approved by the European Commission as the first immunotherap..
AQ
06/28SANOFI : New Soliqua® data shows improved blood sugar control without weight gai..
PU
06/28SANOFI : Nirsevimab shows positive topline results in RSV Phase 2/3 MEDLEY trial
GL
06/28SANOFI : streamlines Consumer Healthcare portfolio in Europe with divestiture of..
PU
06/28Dupixent® (dupilumab) SmPC updated with long-term data reinforcing well-estab..
GL
06/25SANOFI : European Commission approves Aubagio® (teriflunomide) as the first oral..
PU
06/25SANOFI : Availability of the Q2 2021 Memorandum for modelling purposes
AQ
06/25SANOFI : Libtayo® (cemiplimab) approved by the European Commission as the first ..
GL
06/25SANOFI : Libtayo® (cemiplimab) approved by the European Commission for first-lin..
GL
06/18SANOFI : European Commission approves Aubagio® (teriflunomide) as the first oral..
AQ
06/16ER+/ HER2-VE BREAST CANCER PIPELINE : Emerging Therapies and Key pharma players ..
AQ
06/14SANOFI : - New pivotal data at EHA 2021 reinforces sutimlimab as a first-in-clas..
AQ
06/14SANOFI : provides update on Aubagio (teriflunomide) submission for children and ..
AQ
06/11New pivotal data at EHA 2021 reinforces sutimlimab as a first-in-class invest..
GL
06/11SANOFI : provides update on Aubagio® (teriflunomide) submission for children and..
PU
06/08SANOFI : launches its new global employee share ownership plan (Form 6-K)
PU
06/07SANOFI : launches its new global employee share ownership plan
GL
06/07Compatibility with New Insulins Opens Up New Market Opportunities for Brighte..
AQ
06/07SANOFI : partnering with leading academic cooperative groups to study amcenestra..
AQ
06/04Sanofi partnering with leading academic cooperative groups to study amcenestr..
GL
06/03Sanofi launches €3 million Planet Mobilization fund to support employees' env..
GL
06/02SANOFI : A High Bar For Antibody Genus Claims To Meet The Enablement Requirement
AQ
06/01SANOFI : provides update on venglustat clinical program
AQ
05/27SANOFI : Production of another COVID-19 vaccine to begin in weeks
AQ
05/27SANOFI : and GSK initiate global Phase 3 clinical efficacy study of COVID-19 vac..
GL
05/25SANOFI : - Libtayo (cemiplimab) receives positive CHMP opinion for the treatment..
AQ
05/21SANOFI : Longer term data and new analyses for Sarclisa® (isatuximab-irfc) furth..
PU
05/20SANOFI : - Early amcenestrant data featured at ASCO support its potential to bec..
AQ
05/19SANOFI : to showcase data from its transformative oncology pipeline at 2021 ASCO..
GL
05/19Early amcenestrant data featured at ASCO support its potential to become a ne..
GL
05/17SANOFI : Pivotal data at ATS 2021 show Dupixent® (dupilumab) significantly reduc..
GL
05/17SANOFI : -GSK reports success in virus vaccine, after setback
AQ
05/17SANOFI : and GSK COVID-19 vaccine candidate demonstrates strong immune responses..
GL
05/13OROPHARYNGEAL CANCER PIPELINE : Emerging Therapies and Key pharma players involv..
AQ
05/12SANOFI : New data to be featured at EHA 2021 Congress highlight Sanofi's ongoing..
PU
05/12SANOFI : 99.1. Information on Q1 2021 financial results (Form 6-K)
PU
05/12CELLECTIS : and Sanofi partner on alemtuzumab as lymphodepletion agent for allo..
AQ
05/07AMICUS THERAPEUTICS : Appoints Sebastien Martel as Senior Vice President of Stra..
AQ
05/06SANOFI : establishes three-year collaboration with Stanford Medicine to accelera..
AQ
05/04SANOFI : Financial Report
PU
05/04BOARD COMPOSITION : renewals, ratification of a co-opting Director and appointme..
PU
04/30SANOFI : Annual General Meeting of April 30, 2021
GL
04/28SANOFI : continued its growth trajectory. Strong increase in Q1 2021 business EP..
PU
04/28SANOFI : Q1 Earnings Snapshot
AQ
04/28SANOFI : Q1 2021 income statements
PU
04/28SANOFI : Download infographic
PU
04/28SANOFI : Q1 2021 net sales by GBU, franchise, geographic region and product
PU
04/28SANOFI : Présentation (en anglais)
PU
04/28SANOFI : Q1 2021 Press release
PU
04/28SANOFI : Q1 2021 Presentation
PU
04/28SANOFI : continued its growth trajectory. Strong increase in Q1 2021 business EP..
GL
04/26THE LATEST : Sanofi to produce Moderna coronavirus vaccine
AQ
04/26SANOFI : Nirsevimab MELODY Phase III trial met primary endpoint of reducing RSV ..
AQ
04/26Nirsevimab demonstrated protection against respiratory syncytial virus diseas..
GL
04/23SANOFI : New Dupixent® (dupilumab) analyses reinforce long-term safety and effic..
GL
04/20SANOFI : European Commission approves second indication of Sarclisa (isatuximab)..
AQ
04/19SANOFI : completes Kiadis acquisition
AQ
04/19European Commission approves second indication of Sarclisa® (isatuximab) for ..
GL
04/16MUCINOUS CYSTIC NEOPLASM PIPELINE : Emerging Therapies and Key pharma players in..
AQ
04/14SANOFI : After Setbacks, Rollout of New TB Prevention Pills to Start in Six Dist..
AQ
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on SANOFI